Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
- PMID: 27864413
- PMCID: PMC6236919
- DOI: 10.1093/ije/dyw211
Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Abstract
Many questions about the long-term effects of combination antiretroviral therapy (cART) on clinical outcomes in people living with HIV (PLWH) and their impact on health systems remain unanswered. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) was formed in 2005 to pool and harmonize existing longitudinal data on people living with HIV in Europe, to answer key research questions that could not be addressed adequately by individual cohorts. Key research questions include long-term prognosis, rare outcomes, and variations across patient groups, settings and health systems. COHERE uses the HIV Cohorts Data Exchange Protocol, a standardized and validated method of data structure and transfer, to compile data from over 40 cohorts of PLWH residing in Europe, representing 331 481 individuals, including 2808 children (<13), representing 2 135 896 person-years of follow-up. COHERE compiles data on clinical characteristics, antiretroviral therapy and other medications, HIV seroconversion, opportunistic infections, laboratory results and socio demographic data. External collaborators interested in conducting a project in COHERE should submit a project proposal to the Regional Coordinating Centres in Bordeaux and Copenhagen for review by COHERE’s governing bodies (see
Conflict of interest statement
DC was a member of the French Gilead HIV board up until 2015 and gave lectures for Janssen-Cilag, Merck-Sharp & Dohme-Chibret, ViiV and received travel/accommodations/meeting expenses from Gilead, ViiV, Janssen-Cilag. DC also conducted post-marketing studies for Janssen-Cilag, Merck-Sharp & Dohme-Chibret and ViiV. DC is currently a consultant at Innavirvax. HF has received grants from the Swiss National Science Foundation. His institution has received grants from ViiV, Abbvie, MSD, Janssen, Roche, BMS, and Gilead. The other co-authors have no conflicts of interest to declare.
References
-
- Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet. 2003;362:22–9. - PubMed
-
- EuroCoord: Enhancing clinical and epidemiological HIV research in Europe through cohort collaborations. 2014. [cited 2014 5 February]; Available from: http://www.eurocoord.net/
-
- EuroSida. 2015. [cited 6 July, 2015]; Available from: http://www.cphiv.dk/Ongoing-Studies/EuroSIDA/About.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
